Andrew E Ekpenyong (Andrew Ekpenyong)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 6

Top Venues

Life (Basel, Switzerland)

Biomedicines

Journal of biophotonics

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Ashley Abraham, Sukhman Virdi, Nick Herrero, Israel Bryant, Chisom Nwakama, Megha Jacob, Gargee Khaparde, Destiny Jordan, Mackenzie McCuddin, Spencer McKinley, Adam Taylor, Conner Peeples, Andrew E Ekpenyong
Microfluidic Microcirculation Mimetic for Exploring Biophysical Mechanisms of Chemotherapy-Induced Metastasis. Micromachines 14 (9) (2023)
Spencer McKinley, Adam Taylor, Conner Peeples, Megha Jacob, Gargee Khaparde, Yohan A Walter, Andrew E Ekpenyong
Simulated Microgravity-Induced Changes to Drug Response in Cancer Cells Quantified Using Fluorescence Morphometry. Life (Basel, Switzerland) 13 (8) (2023)
Yohan A Walter, Anne Hubbard, Allie Benoit, Erika Jank, Olivia Salas, Destiny Jordan, Andrew E Ekpenyong
Development of In Vitro Assays for Advancing Radioimmunotherapy against Brain Tumors. Biomedicines 10 (8) (2022)
Devika Prasanth, Sindhuja Suresh, Sruti Prathivadhi-Bhayankaram, Michael Mimlitz, Noah Zetocha, Bong Lee, Andrew E Ekpenyong
Microgravity Modulates Effects of Chemotherapeutic Drugs on Cancer Cell Migration. Life (Basel, Switzerland) 10 (9) (2020)
Bong H Lee, Sindhuja Suresh, Andrew E Ekpenyong
Fluorescence intensity modulation of CdSe/ZnS quantum dots assesses reactive oxygen species during chemotherapy and radiotherapy for cancer cells. Journal of biophotonics 12 (2) (2018)
Andrew E Ekpenyong, Nicole Toepfner, Christine Fiddler, Maik Herbig, Wenhong Li, Gheorghe Cojoc, Charlotte Summers, Jochen Guck, Edwin R Chilvers
Mechanical deformation induces depolarization of neutrophils. Science advances 3 (6) (2017)

Andrew E Ekpenyong.css-eqlu8i{font-size:small;padding-left:4px;} (Andrew Ekpenyong)

Publication Activity (10 Years)

Top Topics

Top Venues

Andrew E Ekpenyong (Andrew Ekpenyong)